Search results

  1. R

    Sharing+Discuss Option Trades/Strategies

    You do realize that biotech stocks perform entirely differently than your generic "stocks." There is no reversion to the mean in biotech stocks. This could be a binary event. It may not be possible to "manage." Did your research tell you how many profitable products SVNT has or that may be...
  2. R

    Sharing+Discuss Option Trades/Strategies

    Are we talking about TOL? Would you mind telling me how you calculate the p/p at 76-78% Are you using Black Scholes? The current IV alone today was 57.5.
  3. R

    Sharing+Discuss Option Trades/Strategies

    Perhaps more inexplicable than SVNT, is TOL. PM, let's calculate your return on a spread with expiry in Sept. (you couldn't find the stikes you desired in July???) .30 credit on a $1,500 spread for 106 days ($7 comm) is 5.4% per month on a housing stock thru the summer (to each his own). BTW...
  4. R

    Sharing+Discuss Option Trades/Strategies

    May not be that silly, SVNT is a biotech with an FDA decision due this month. Fasten your seatbelt. Savient Pharmaceuticals, Inc. (SVNT) today announced that its biologics license application (BLA) for KRYSTEXXA(TM) (pegloticase), a novel biological drug for treatment failure gout (TFG)...
  5. R

    Dollar is getting slaughtered.

    Maybe it was polite, nervous laughter.
  6. R

    Dollar is getting slaughtered.

    I heard Geithner was laughed at by a student audience in China when he assured them that Chinese assets in the US were "safe." Source I believe was FT, US media is not reporting it.
  7. R

    Sharing+Discuss Option Trades/Strategies

    Sorry, I've been working 12 hours a day dealing with recession hit business loans. I used 100 day hv, not current IV (sorry, I misled in a reply). HV on Monday was 58, Current IV on Tuesday and after a pop up in the stock was 45 and would have shown an 80% PP. There is a bias in time period...
  8. R

    Sharing+Discuss Option Trades/Strategies

    Probaility of profit is 73% using average IV and Black-Scholes option pricing model.
  9. R

    Direxion Financial ETF - 6/1

    Do you thinks it's wise to hold this 3X ETF over weekend - for me it is a trading vehicle.
  10. R

    Sharing+Discuss Option Trades/Strategies

    PM, hoping to be constructive. I'm not crazy about this trade on it's own terms. I see a .73 p/p based on 100 day hv.; less using a longer history and with a relatively modest .75 credit for a 5 point spread with 46 days to expiry I'd pass on this credit spread. That's just my opinion...
  11. R

    Option Strategy Adjustments

    PM, get a clue. Per your own admission, change your handle to Put Novice, there's no shame in that. Put "master" is off putting -we all have a lot to learn ... and stop calling other people "trolls."
  12. R

    What happened to Putzi?

    Under a bridge somewhere muttering about "trolls."
  13. R

    What happened to Putzi?

    Recruited for job in TARP.
  14. R

    Economics Reporter @ NYT Nearly Gets Foreclosed - He "Should Have Seen It Coming"'

    The man is a fool on many levels. I might have, but will not now buy his book.
  15. R

    what do you use to perdict the future?

    The future ain't what it used to be. Yogi Berra (1925 - )
  16. R

    Long Term Calls on UDN

    I like the idea. But I'm in the ETF.
  17. R

    B/S Volatility and StdDevs

    Why don't you narrow your universe (rather than all stocks) and use historical volatilties?
  18. R

    Why did I not get an assignment notice?

    Why don't you address his concerns instead of mis-reading my syntax?
  19. R

    Why did I not get an assignment notice?

    Don't worry, you're in an enviable position. Selling more calls, although it will increase your taxes at this point, will still incrementally increase your wealth (unless it puts you into a higher bracket, hah). Why sell or have it assigned from you at all? Hold onto it for a Long Term...
  20. R

    Which broker do you use?

    Why don't you check out the user reviews of Brokers - 3rd tab on the top.
Back
Top